Exogenous hormone use not associated with increased breast cancer risk
Benefits of exogenous hormone use, as well as data indicating no association with increased breast cancer risk, were discussed at The Menopause Society 2023 Annual Meeting.
The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels
Best nonhormone methods for managing vasomotor symptoms
The most recommended and non-recommended methods of nonhormone therapy for treatment of vasomotor symptoms were discussed at The Menopause Society 2023 Annual Conference.
Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2
This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.
PTSD linked to worse sexual functioning in midlife women
A recent study measuring sexual functioning in women with post-traumatic stress disorder was discussed at The Menopause Society 2023 Annual Meeting.
How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care
2 Clarke Drive Cranbury, NJ 08512